BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Smith AM, Davey K, Tsartsalis S, Khozoie C, Fancy N, Tang SS, Liaptsi E, Weinert M, McGarry A, Muirhead RCJ, Gentleman S, Owen DR, Matthews PM. Diverse human astrocyte and microglial transcriptional responses to Alzheimer's pathology. Acta Neuropathol 2022;143:75-91. [PMID: 34767070 DOI: 10.1007/s00401-021-02372-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Saura CA, Deprada A, Capilla-López MD, Parra-Damas A. Revealing cell vulnerability in Alzheimer's disease by single-cell transcriptomics. Semin Cell Dev Biol 2023;139:73-83. [PMID: 35623983 DOI: 10.1016/j.semcdb.2022.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Liu Y, Tan Y, Zhang Z, Li H, Yi M, Zhang Z, Hui S, Peng W. Neuroimmune mechanisms underlying Alzheimer's disease: Insights into central and peripheral immune cell crosstalk. Ageing Res Rev 2023;84:101831. [PMID: 36565960 DOI: 10.1016/j.arr.2022.101831] [Reference Citation Analysis]
3 Aghaizu ND, Jolly S, Samra SK, Kalmar B, Craessaerts K, Greensmith L, Salinas PC, De Strooper B, Whiting PJ. Microglial Expression of the Wnt Signaling Modulator DKK2 Differs between Human Alzheimer's Disease Brains and Mouse Neurodegeneration Models. eNeuro 2023;10:ENEURO. [PMID: 36599670 DOI: 10.1523/ENEURO.0306-22.2022] [Reference Citation Analysis]
4 Murdock MH, Tsai LH. Insights into Alzheimer's disease from single-cell genomic approaches. Nat Neurosci 2023. [PMID: 36593328 DOI: 10.1038/s41593-022-01222-2] [Reference Citation Analysis]
5 Wang ZB, Ma YH, Sun Y, Tan L, Wang HF, Yu JT; Alzheimer’s Disease Neuroimaging Initiative. Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer's disease. J Neuroinflammation 2022;19:316. [PMID: 36578067 DOI: 10.1186/s12974-022-02679-5] [Reference Citation Analysis]
6 Ceyzériat K, Zilli T, Millet P, Koutsouvelis N, Dipasquale G, Fossey C, Cailly T, Fabis F, Frisoni GB, Garibotto V, Tournier BB. Low-dose brain irradiation normalizes TSPO and CLUSTERIN levels and promotes the non-amyloidogenic pathway in pre-symptomatic TgF344-AD rats. J Neuroinflammation 2022;19:311. [PMID: 36550510 DOI: 10.1186/s12974-022-02673-x] [Reference Citation Analysis]
7 Serrano-pozo A, Li Z, Woodbury ME, Muñoz-castro C, Wachter A, Jayakumar R, Bryant AG, Noori A, Welikovitch LA, Hu M, Zhao K, Liao F, Lin G, Pastika T, Tamm J, Abdourahman A, Kwon T, Bennett RE, Talanian RV, Biber K, Karran EH, Hyman BT, Das S. Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease.. [DOI: 10.1101/2022.12.03.518999] [Reference Citation Analysis]
8 Asante I, Louie S, Yassine HN. Uncovering mechanisms of brain inflammation in Alzheimer's disease with APOE4: Application of single cell-type lipidomics. Ann N Y Acad Sci 2022. [PMID: 36200578 DOI: 10.1111/nyas.14907] [Reference Citation Analysis]
9 Sutter PA, Crocker SJ. Glia as antigen-presenting cells in the central nervous system. Curr Opin Neurobiol 2022;77:102646. [PMID: 36371828 DOI: 10.1016/j.conb.2022.102646] [Reference Citation Analysis]
10 Rodríguez-giraldo M, González-reyes RE, Ramírez-guerrero S, Bonilla-trilleras CE, Guardo-maya S, Nava-mesa MO. Astrocytes as a Therapeutic Target in Alzheimer’s Disease–Comprehensive Review and Recent Developments. IJMS 2022;23:13630. [DOI: 10.3390/ijms232113630] [Reference Citation Analysis]
11 Coales I, Tsartsalis S, Fancy N, Weinert M, Clode D, Owen D, Matthews PM. Alzheimer's disease-related transcriptional sex differences in myeloid cells. J Neuroinflammation 2022;19:247. [PMID: 36199077 DOI: 10.1186/s12974-022-02604-w] [Reference Citation Analysis]
12 Gao W, Kong W, Wang S, Wen G, Yu Y. Biomarker Genes Discovery of Alzheimer’s Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia. Brain Sciences 2022;12:1196. [DOI: 10.3390/brainsci12091196] [Reference Citation Analysis]
13 Mills WA 3rd, Eyo UB. TREMble Before TREM2: The Mighty Microglial Receptor Conferring Neuroprotective Properties in TDP-43 Mediated Neurodegeneration. Neurosci Bull 2023;39:163-6. [PMID: 35978262 DOI: 10.1007/s12264-022-00944-4] [Reference Citation Analysis]
14 St-pierre M, Vanderzwaag J, Loewen S, Tremblay M. All roads lead to heterogeneity: The complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer’s disease. Front Cell Neurosci 2022;16:932572. [DOI: 10.3389/fncel.2022.932572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Fancy N, Willumsen N, Tsartsalis S, Khozoie C, Mcgarry A, Muirhead RC, Schneegans E, Davey K, Chau VM, Smith AM, Scotton W, Hardy J, Huh D, Matthews PM, Jackson JS. Mechanisms contributing to differential genetic risks for TREM2 R47H and R62H variants in Alzheimer’s Disease.. [DOI: 10.1101/2022.07.12.22277509] [Reference Citation Analysis]
16 Nutma E, Fancy N, Weinert M, Marzin MC, Tsartsalis S, Muirhead RC, Falk I, de Bruin J, Hollaus D, Pieterman R, Anink J, Story D, Chandran S, Tang J, Trolese MC, Saito T, Saido TC, Wiltshire K, Beltran-lobo P, Philips A, Antel J, Healy L, Moore CS, Bendotti C, Aronica E, Radulescu CI, Barnes SJ, Hampton DW, van der Valk P, Jacobson S, Matthews PM, Amor S, Owen DR. Translocator protein is a marker of activated microglia in rodent models but not human neurodegenerative diseases.. [DOI: 10.1101/2022.05.11.491453] [Reference Citation Analysis]
17 Aghaizu ND, Jolly S, Samra SK, Kalmar B, Craessaerts K, Greensmith L, Salinas PC, Strooper BD, Whiting PJ. Microglial expression of the Wnt signalling modulator DKK2 differs between human Alzheimer’s disease brains and mouse neurodegeneration models.. [DOI: 10.1101/2022.05.05.490649] [Reference Citation Analysis]
18 Kecheliev V, Boss L, Maheshwari U, Konietzko U, Keller A, Razansky D, Nitsch RM, Klohs J, Ni R. Aquaporin 4 is differentially increased and depolarized in association with tau and amyloid-beta.. [DOI: 10.1101/2022.04.26.489273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ceyzériat K, Meyer L, Bouteldja F, Tsartsalis S, Amossé Q, Middleton RJ, Liu G, Banati RB, Zilli T, Garibotto V, Millet P, Tournier BB. Knockout of TSPO delays and reduces amyloid, Tau, astrocytosis and behavioral dysfunctions in Alzheimer’s disease.. [DOI: 10.1101/2022.03.26.485919] [Reference Citation Analysis]
20 Seeker LA, Bestard-cuche N, Jäkel S, Kazakou N, Bøstrand SMK, Kilpatrick AM, Van Bruggen D, Kabbe M, Pohl FB, Moslehi Z, Henderson NC, Vallejos CA, Manno GL, Castelo-branco G, Williams A. Marked regional glial heterogeneity in the human white matter of the central nervous system.. [DOI: 10.1101/2022.03.22.485367] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Paasila PJ, Aramideh JA, Sutherland GT, Graeber MB. Synapses, Microglia, and Lipids in Alzheimer’s Disease. Front Neurosci 2022;15:778822. [DOI: 10.3389/fnins.2021.778822] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Cholesterol Dysmetabolism in Alzheimer's Disease: A Starring Role for Astrocytes? Antioxidants (Basel) 2021;10:1890. [PMID: 34943002 DOI: 10.3390/antiox10121890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]